Advancing Care. Empowering Clinicians.Explore hysteroscopy, endometriosis, vulvovaginal health and LaEvita research, through to sleep apnea assessment in pregnancy.
← All specialtiesAn intravaginal diode laser approach described by the manufacturer for vaginal atrophy and genitourinary syndrome of menopause. Two LEONARDO studies reported symptom improvement in small uncontrolled groups; this is early evidence and does not establish standard therapy.
LaEvita / LEONARDO: an early GSM study →
Brand / device family
LEONARDO for GSM: follow-up to six months →
Brand / device family
The LaEvita brochure lists stress urinary incontinence applications with a dedicated kit. Linked GSM evidence does not automatically establish benefits for incontinence; urogynecological evaluation and condition-specific evidence remain necessary.
The manufacturer’s gynecology portfolio also covers conization, cervicovaginal dysplasia, and condyloma. Diagnosis, histopathology requirements, and fiber or handpiece selection determine procedural suitability.
Labial surgery for functional or aesthetic needs following individual assessment. The curated study used Er:YAG Fotona, not biolitec. LEONARDO-specific labiaplasty documentation has not been verified, so it is not mapped as an SMCGD product application.
Laser labiaplasty: satisfaction and complications in a series of 80 patients →
Procedure evidence · Other devices
Introduction to applications for uterine polyps, myomas, and septa with suitable hysteroscopy fibres and instruments.
Laser applications for endometriosis using a laparoscopic approach. Technique selection depends on lesions, treatment objectives, and clinical judgment.
Pregnancy, including trimester III, can warrant assessment for sleep-disordered breathing. CPAP is presented as OSA treatment following clinical assessment, not a routine requirement for every pregnant woman.
CPAP in high-risk pregnancy with OSA →
Brands in our portfolio
PAP in pregnancy: inconsistent findings →
General clinical evidence
CPAP, OSA symptoms, and cardiovascular outcomes →
General clinical evidence
LaEvita covers intravaginal laser therapy for GSM symptoms. Labiaplasty surgically changes labial tissue. Their objectives, target anatomy, accessories, and evidence differ.
The curated LEONARDO studies included 26 and 22 patients without control groups. These early findings do not establish superiority to standard treatment or long-term safety.
Read evidence in context →Discuss equipment configuration, training, and service support with the SMCGD team.